Amanote Research
Register
Sign In
Diffuse Mesothelin Expression Correlates With Prolonged Patient Survival in Ovarian Serous Carcinoma
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-1397
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
February 1, 2006
Authors
M. J. Yen
Publisher
American Association for Cancer Research (AACR)
Related search
DEF6 Expression in Ovarian Carcinoma Correlates With Poor Patient Survival
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Surprise Lymph Node Histology in a Patient With Ovarian Serous Carcinoma
Case Reports in Obstetrics and Gynecology
Placental Type Alkaline Phosphatase Tissue Expression in Ovarian Serous Carcinoma
Cancer Biomarkers
Medicine
Cancer Research
Oncology
Genetics
Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma From Breast Carcinoma in Effusions
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Distinct Gene Expression Profiles Associated With Clinical Outcomes in Patients With Ovarian Clear Cell Carcinoma and High-Grade Serous Ovarian Carcinoma
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
High ALDH1A1 Expression Correlates With Poor Survival in Papillary Thyroid Carcinoma
World Journal of Surgical Oncology
Surgery
Oncology
Expression of Ku70 Correlates With Survival in Carcinoma of the Cervix
British Journal of Cancer
Cancer Research
Oncology
Thrombomodulin Expression in Colorectal Carcinoma Is Protective and Correlates With Survival
British Journal of Cancer
Cancer Research
Oncology
Altered eIF6 and Dicer Expression Is Associated With Clinicopathological Features in Ovarian Serous Carcinoma Patients
Modern Pathology
Forensic Medicine
Pathology